Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD

References

• Global Initiative for Chronic Obstructive Lung Disease. Report global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2019 report. Available from: www.goldcopd.org.
   Google Scholar
• Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol. 2012;48:247–257. doi:10.1016/j.arbres.2012.04.00122561012
   PubMed Web of Science ®Google Scholar
• Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48:279–285. doi:10.3109/02770903.2011.55557621323613
   PubMed Web of Science ®Google Scholar
• McDonald VM, Simpson JL, Higgins I, Gibson PG. Multidimensional assessment of older people with asthma and COPD: clinical management and health status. Age Ageing. 2011;40:42–49. doi:10.1093/ageing/afq13421087988
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, van Zyl-smit RN, Agusti A. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. 2015;3:719–728. doi:10.1016/S2213-2600(15)00254-426255108
   PubMed Web of Science ®Google Scholar
• Nielsen M, Barnes CB, Ulrik CS. Clinical characteristics of the asthma-COPD overlap syndrome-a systematic review. Int J Chron Obstruct Pulmon Dis. 2015;10:1443–1454. doi:10.2147/COPD.S8536326251584
   PubMed Web of Science ®Google Scholar
• Shaya FT, Dongyi D, Akazawa MO, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest. 2008;134:14–19. doi:10.1378/chest.07-231718339789
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186:48–55. doi:10.1164/rccm.201108-1553OC22447964
   PubMed Web of Science ®Google Scholar
• Corlateanu A, Covantev S, Mathioudakis A, Botnaru V, Siafakas N. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current evidence and future research directions. COPD Res Prac. 2017;3:6. doi:10.1186/s40749-017-0025-x
   Google Scholar
• Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J. 2006;27:964–981. doi:10.1183/09031936.06.0007210516446316
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Román-Rodríguez M, Miravitlles M. Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD? Int J Chronic Obstructive Pulm Dis. 2015;10:1745–1752.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma, Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of disease of chronic airflow limitation: asthma, COPD, and Asthma–COPD Overlap Syndrome (ACOS). Available from: http://www.ginasthma.org/local/uploads/files/ACOS_2015.pdf. Accessed 220, 2018.
   Google Scholar
• Donohue JF, Herje N, Crater G, Rickard K. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study. Int J Chronic Obstructive Pulm Dis. 2014;9:745–751. doi:10.2147/COPD
   PubMed Web of Science ®Google Scholar
• Tamada T, Sugiura H, Takahashi T, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chronic Obstructive Pulm Dis. 2015;10:2169–2176. doi:10.2147/COPD.S88274
   PubMed Web of Science ®Google Scholar
• Takayama Y, Ohnishi H, Ogasawara F, et al. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma–COPD overlap. Int J Chronic Obstructive Pulm Dis. 2018;13:2525–2532. doi:10.2147/COPD
   PubMed Web of Science ®Google Scholar
• McDonald CF. Eosinophil Biology in COPD. N Engl J Med. 2017;377:1680–1682. doi:10.1056/NEJMe171032628893123
   PubMed Web of Science ®Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease — the copenhagen general population study. Am J Respir Crit Care Med. 2016;193:965–974. doi:10.1164/rccm.201509-1869OC26641631
   PubMed Web of Science ®Google Scholar
• Matthes S, Stadler J, Barton J, et al. Asthma features in severe COPD: identifying treatable traits. Respir Med. 2018;145:89–94. doi:10.1016/j.rmed.2018.10.02730509722
   PubMed Web of Science ®Google Scholar
• Pavord ID. Biologics and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141:1983–1991. doi:10.1016/j.jaci.2018.04.02029729941
   PubMed Web of Science ®Google Scholar
• Alving K, Malinovschi A. Basic aspects of exhaled nitric oxide. Eur Respir Soc Monogr. 2010;49:1–31.
   Google Scholar
• Stirling RG, van Rensen EL, Barnes PJ, Chung KF. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001;164:1403–1409. doi:10.1164/ajrccm.164.8.201000211704586
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Pavord ID, Russell REK. Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017;5:747–759. doi:10.1016/S2213-2600(17)30217-528601554
   PubMed Web of Science ®Google Scholar
• Pavord ID, Chanez P, Criner GJ, Kerstjens HAM, Korn S. Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N Engl J Med. 2017;377:1613–1629. doi:10.1056/NEJMoa170820828893134
   PubMed Web of Science ®Google Scholar
• Maltby S, Gibson PG, Powell H, McDonald VM. Omalizumab treatment response in a population with severe allergic asthma and overlapping. COPD Chest. 2017;151:78–89. doi:10.1016/j.chest.2016.09.03527742181
   PubMed Web of Science ®Google Scholar
• Chinese Thoracic Society. The Chinese national guidelines of pulmonary function test.Chin J Tuberc Respir Dis. 2014;37:566–571. Available from http://zhjhhhxzz.yiigle.com/CN112147201408/860037.htm. Accessed November 11, 2019.
   Google Scholar
• American Thoracic Society,European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–930. doi:10.1164/rccm.200406-710ST15817806
   PubMed Web of Science ®Google Scholar
• Couillard S, Larivée P, Courteau J, Vanasse A. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151:366–373. doi:10.1016/j.chest.2016.10.00327746201
   PubMed Web of Science ®Google Scholar
• Sin DD. Asthma-copd overlap syndrome: what we know and what we don’t. Tuberc Respir Dis. 2017;80:11–20. doi:10.4046/trd.2017.80.1.11
   Web of Science ®Google Scholar
• George L, Brightling CE. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther Adv Chronic Dis. 2016;7:34–51. doi:10.1177/204062231560925126770668
   PubMed Web of Science ®Google Scholar
• Carr TF, Zeki AA, Kraft M. Eosinophilic and Noneosinophilic Asthma. Am J Respir Crit Care Med. 2018;197:22–37. doi:10.1164/rccm.201611-2232PP28910134
   PubMed Web of Science ®Google Scholar
• Río Ramírez MT, Juretschke Moragues MA, Fernández González R, et al. Value of exhaled nitric oxide (FeNO) and eosinophilia during the exacerbations of chronic obstructive pulmonary disease requiring hospital admission. Int J Chronic Obstructive Pulm Dis. 2018;15:369–376. doi:10.1080/15412555.2018.1482532
   Web of Science ®Google Scholar
• Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996;153:454–457. doi:10.1164/ajrccm.153.1.85421588542158
   PubMed Web of Science ®Google Scholar